Dr Simon Agwale is the chief executive officer, ofInnovative Biotech Nigeria and Innovative Biotech USA. He also chairs the ...
In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...
In the twentieth century, the development and delivery of vaccines as part of large, systematic immunization programs helped to address many health inequities. However, safety concerns due to ...